Addressing Sleep Problems in Older Adults

Sponsor
Mayo Clinic (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02593981
Collaborator
(none)
0
1
2
13
0

Study Details

Study Description

Brief Summary

As many as 57% of older adults complain of major disruption of sleep, 29% struggle to fall asleep and 19% complain of early-morning awakening. The implications of this sleep deprivation are sobering, particularly among older individuals.

The primary goal of this study is to determine whether a palatable foodstuff which contains a fruit/honey drink and which is taken every evening before bedtime leads to improved sleep in community-living individuals with sleep problems.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Fruit/Honey drink
  • Dietary Supplement: Placebo
N/A

Detailed Description

This is a randomized, placebo-controlled double-blinded pilot study to explore the use of a fruit/honey drink product for improving sleep in older adults. The purpose of this study is to estimate the effects of a fruit/honey drink using various assessment tools when used as short-term intervention.

This trial proposes to enroll a total of 60 community based older adults. All study patients will be instructed to take the study product every day for 28 days. During which time, study subjects will return weekly to complete study visits for a total of 4 visits.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
To Sleep, Perchance to Dream: A Randomized, Placebo-Controlled Study to Test a Fruit/Honey-Based Foodstuff for Sleep Problems in Older Adults
Anticipated Study Start Date :
Mar 1, 2018
Anticipated Primary Completion Date :
Feb 1, 2019
Anticipated Study Completion Date :
Apr 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Fruit/Honey Drink

Fruit/Honey Drink (2 canisters) will be taken orally twice a day. Subjects will consume the drink on days 1 through 28.

Dietary Supplement: Fruit/Honey drink
2 canisters of powder containing fruit/honey mix to be mixed with water and ingested twice a day for 28 days

Placebo Comparator: Placebo

Placebo (2 canisters) will be taken orally twice a day. Subjects will consume the placebo drink on days 1 through 28.

Dietary Supplement: Placebo
2 canisters of Placebo powder containing non-active ingredient to be mixed with water and ingested twice a day for 28 days

Outcome Measures

Primary Outcome Measures

  1. PSQI score [28 days]

    Pittsburgh Sleep Quality Index (PSQI):

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Age ≥ 60 years old at the time of study registration.

  2. Individual describes trouble either falling asleep or staying asleep at study entry.

  3. Willing to participate in all aspects of the study.

  4. Willing to avoid kiwifruit, cherry, and honey for 4 weeks while on this study.

  5. Willing to avoid changes to current sleep medications (may use a stable dose of a currently prescribe sleep medication during the first 4 weeks after stating the intervention).

Exclusion Criteria:
  1. Allergic to kiwifruit, cherries, honey, apples, or bananas.

  2. Hospitalized or living in a care facility at the time of enrollment.

  3. Clinical evidence of active malignant disease (cancer), as per healthcare provider's clinical judgment.

  4. Any cancer therapy (for example, chemotherapy, hormonal therapy, radiation, surgery, immunotherapy) in the preceding 3 months.

  5. Healthcare provider does not think that study candidate has a specific health problem that precludes participation.

  6. Allergy or intolerance of milk products.

  7. Women of child bearing potential.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mayo Clinic Rochester Minnesota United States 55905

Sponsors and Collaborators

  • Mayo Clinic

Investigators

  • Principal Investigator: Brent Bauer, MD, Mayo Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Brent A. Bauer, Principal Investigator, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT02593981
Other Study ID Numbers:
  • 15-006031
First Posted:
Nov 1, 2015
Last Update Posted:
Dec 11, 2018
Last Verified:
Dec 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Brent A. Bauer, Principal Investigator, Mayo Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 11, 2018